LEIDEN, The Netherlands, April 5,
2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming"
or "the Company") ( Euronext: PHARM / Nasdaq: PHAR) announces the
filing of its Annual Report for the year ended December 31, 2022 (the "Period"). The Annual
Report is available under the Financial Documents section of the
Pharming website.
The Company has also filed its Annual Report on Form 20-F with
the U.S. Securities and Exchange Commission (SEC) for the Period.
The 2022 Annual Report on Form 20-F can be found on Pharming.com
and through the SEC website once it has been filed.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is
a global biopharmaceutical company dedicated to transforming the
lives of patients with rare, debilitating, and life-threatening
diseases. Pharming is commercializing and developing an innovative
portfolio of protein replacement therapies and precision medicines,
including small molecules, biologics, and gene therapies that are
in early to late-stage development. Pharming is headquartered in
Leiden, Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle
East, Africa, and
Asia-Pacific. For more
information, visit www.pharming.com or follow us on
LinkedIn.
Inside Information
This press release relates to the disclosure of information that
qualifies, or may have qualified, as inside information within the
meaning of Article 7(1) of the EU Market Abuse Regulation.
For further public information, contact:
Pharming Group, Leiden, The
Netherlands
Michael Levitan, VP Investor
Relations & Corporate Communications
T: +1 (908) 705 1696
Heather Robertson, Investor
Relations & Corporate Communications Manager
T: +31 71 5247 400
E: investor@pharming.com
FTI Consulting, London,
UK
Victoria Foster
Mitchell/Alex
Shaw
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon
Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Logo -
https://mma.prnewswire.com/media/2047443/Pharming_Group_NV__Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/pharming-group-announces-the-filing-of-its-2022-annual-report-and-form-20-f-301789786.html